GlassScriptPhysician profile
Jasvinder Pal Singh
NPI 1114985686
$6,438.74
in general payments reported to CMS, 2019-2025
15 companies · $1,027 in 2025
The $1,027 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,320 · 2020: $92.50 · 2021: $230 · 2022: $1,171 · 2023: $1,350 · 2024: $1,249 · 2025: $1,027.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,587 · Food and Beverage: $1,039.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,586.85 |
| Food and Beverage | $1,039.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $2,018.02 | 2022-2023 | Single Use Suction Valve (Sterile), Olympus |
| Medtronic, INC. | $1,741.87 | 2024-2025 | Illumisite, Intellis Adaptivestim |
| Veran Medical Technologies, INC. | $1,298.78 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $265.77 | 2022-2025 | |
| Glaxosmithkline, LLC. | $178.64 | 2023-2025 | |
| Inspire Medical Systems, INC. | $166.05 | 2022 | |
| Avadel Cns Pharmaceuticals, LLC | $149.99 | 2025 | Lumryz |
| United Therapeutics Corporation | $147.82 | 2024 | Tyvaso |
| Cardiovascular Systems INC. | $142.83 | 2021 | |
| Stimwave Technologies Incorporated | $92.50 | 2020 | |
| Boston Scientific Corporation | $86.84 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $47.18 | 2022 | |
| Paratek Pharmaceuticals, INC. | $40.74 | 2022 | |
| Recor Medical INC | $40.74 | 2025 | Paradise Ultrasound Renal Denervation System |
| Seqirus USA INC | $20.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jasvinder Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.